Molecular Basis of a Dominant SARS-CoV-2 Spike-Derived Epitope Presented by HLA-A*02:01 Recognised by a Public TCR
Christopher Szeto(La Trobe University), Stéphanie Gras(La Trobe University), Alan Riboldi‐Tunnicliffe(Australian Nuclear Science and Technology Organisation), Corey Smith(QIMR Berghofer Medical Research Institute), Demetra S.M. Chatzileontiadou(La Trobe University), Christian A. Lobos(La Trobe University), Andrea Nguyen(Monash Health), Emma J. Grant(La Trobe University), Dhilshan Jayasinghe(La Trobe University)
Cited by 32
Related Papers
Mechanism and inhibition of the papain‐like protease, PLpro, of SARS‐CoV‐2
|The EMBO Journal|2020|499
Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition
|Nature Medicine|2018|282
Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor Immunity
|Cancer Discovery|2019|272
Prospective study of the human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients.
|Journal of Clinical Pathology|1984|261